サマリー

市場の分析と洞察。勃起不全の世界市場
主要ブランドの特許切れにより、勃起不全の世界市場規模は2021年に48億6000万米ドル、2028年には81億米ドルに再調整されると予測され、レビュー期間中のCAGRは7.04%となっています。
中国の勃起不全の市場規模は2021年に7億米ドル、米国と欧州の勃起不全はそれぞれ1億9153万米ドル、1億2379万米ドルとされています。2021年の米国の割合は39.42％、中国とヨーロッパはそれぞれ14.41％と25.45％で、中国の割合は2028年には16.8％に達すると予測され、2022年から2028年のCAGRは9.06％と引き続く見通しである。アジアでは日本、韓国が注目すべき市場であり、2022年から2028年までのCAGRはそれぞれ8.29%、7.83%となっています。ヨーロッパの勃起不全については、ドイツが2028年までに3億6,335万米ドルに達すると予測され、予測期間中のCAGRは5.45%に達します。
勃起不全の世界的な主要メーカーは、Eli Lilly、Pfizer、Bayer、BaiYunShan General Factory、S.K. Chemicals、Teva Pharma、Dong-A ST、Petros Pharmaceuticals、Seoul Pharmaなどである。2021年、世界の上位5社の売上高シェアは約26.57％。
世界の勃起不全の範囲とセグメント
勃起不全市場は、タイプ別、用途別に分類されます。世界の勃起不全市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てています。
企業別
Eli Lilly
ファイザー
バイエル
白雲山綜合工場
エスケイケミカルズ
テバファーマ
東亜ST
ペトロス製薬
ソウル・ファーマ
八邦薬局

種類別セグメント
シルデナフィル
タダラフィル
その他

用途別セグメント
病院薬局
個人クリニック
小売薬局
電子商取引（B2B）
電子商取引（B2C）

地域別セグメント
北アメリカ
米国
カナダ
メキシコ

アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア

欧州
ドイツ
フランス
英国
イタリア
ロシア

ラテンアメリカ
ブラジル
アルゼンチン

中東・アフリカ
トルコ
サウジアラビア
UAE
エジプト

ページTOPに戻る

目次

1 STUDY COVERAGE 1
1.1 Erectile Dysfunction Product Introduction 1
1.2 Market by Type 1
1.2.1 Global Erectile Dysfunction Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1
1.2.2 Sildenafil 3
1.2.3 Tadalafil 4
1.2.4 Others 5
1.3 Market by Application 6
1.3.1 Global Erectile Dysfunction Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 6
1.3.2 Hospital Pharmacies 8
1.3.3 Private Clinics 9
1.3.4 Retail Pharmacies 9
1.3.5 E-Commerce (B2B) 10
1.3.6 E-Commerce (B2C) 10
1.4 Study Objectives 10
1.5 Years Considered 11
2 EXECUTIVE SUMMARY 12
2.1 Global Erectile Dysfunction Sales Estimates and Forecasts 2017-2028 12
2.2 Global Erectile Dysfunction Revenue Estimates and Forecasts 2017-2028 12
2.3 Global Erectile Dysfunction Revenue by Region: 2017 VS 2021 VS 2028 14
2.4 Global Erectile Dysfunction Sales by Region 15
2.4.1 Global Erectile Dysfunction Sales by Region (2017-2022) 15
2.4.2 Global Sales Erectile Dysfunction by Region (2023-2028) 16
2.5 Global Erectile Dysfunction Revenue by Region 17
2.5.1 Global Erectile Dysfunction Revenue by Region (2017-2022) 17
2.5.2 Global Erectile Dysfunction Revenue by Region (2023-2028) 18
2.6 North America 19
2.7 Europe 20
2.8 Asia-Pacific 21
2.9 Latin America 22
2.10 Middle East & Africa 23
3 COMPETITION BY MANUFACTURERS 24
3.1 Global Erectile Dysfunction Sales by Manufacturers 24
3.1.1 Global Erectile Dysfunction Sales by Manufacturers (2017-2022) 24
3.1.2 Global Erectile Dysfunction Sales Market Share by Manufacturers (2017-2022) 25
3.1.3 Global Top 3 and Top 5 Largest Manufacturers of Erectile Dysfunction in 2021 25
3.2 Global Erectile Dysfunction Revenue by Manufacturers 26
3.2.1 Global Erectile Dysfunction Revenue by Manufacturers (2017-2022) 26
3.2.2 Global Erectile Dysfunction Revenue Market Share by Manufacturers (2017-2022) 27
3.2.3 Global Top 3 and Top 5 Companies by Erectile Dysfunction Revenue in 2021 27
3.3 Global Erectile Dysfunction Sales Price by Manufacturers (2017-2022) 28
3.4 Analysis of Competitive Landscape 29
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 29
3.4.2 Global Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 30
3.4.3 Global Erectile Dysfunction Manufacturers Geographical Distribution 31
3.5 Mergers & Acquisitions, Expansion Plans 32
4 MARKET SIZE BY TYPE 34
4.1 Global Erectile Dysfunction Sales by Type 34
4.1.1 Global Erectile Dysfunction Historical Sales by Type (2017-2022) 34
4.1.2 Global Erectile Dysfunction Forecasted Sales by Type (2023-2028) 34
4.1.3 Global Erectile Dysfunction Sales Market Share by Type (2017-2028) 34
4.2 Global Erectile Dysfunction Revenue by Type 35
4.2.1 Global Erectile Dysfunction Historical Revenue by Type (2017-2022) 35
4.2.2 Global Erectile Dysfunction Forecasted Revenue by Type (2023-2028) 36
4.2.3 Global Erectile Dysfunction Revenue Market Share by Type (2017-2028) 36
4.3 Global Erectile Dysfunction Price by Type 37
4.3.1 Global Erectile Dysfunction Price by Type (2017-2022) 37
4.3.2 Global Erectile Dysfunction Price Forecast by Type (2023-2028) 37
5 MARKET SIZE BY APPLICATION 38
5.1 Global Erectile Dysfunction Sales by Application 38
5.1.1 Global Erectile Dysfunction Historical Sales by Application (2017-2022) 38
5.1.2 Global Erectile Dysfunction Forecasted Sales by Application (2023-2028) 38
5.1.3 Global Erectile Dysfunction Sales Market Share by Application (2017-2028) 38
5.2 Global Erectile Dysfunction Revenue by Application 40
5.2.1 Global Erectile Dysfunction Historical Revenue by Application (2017-2022) 40
5.2.2 Global Erectile Dysfunction Forecasted Revenue by Application (2023-2028) 40
5.2.3 Global Erectile Dysfunction Revenue Market Share by Application (2017-2028) 40
5.3 Global Erectile Dysfunction Price by Application 41
5.3.1 Global Erectile Dysfunction Price by Application (2017-2022) 41
5.3.2 Global Erectile Dysfunction Price Forecast by Application (2023-2028) 42
6 NORTH AMERICA 43
6.1 North America Erectile Dysfunction Market Size by Type 43
6.1.1 North America Erectile Dysfunction Sales by Type (2017-2028) 43
6.1.2 North America Erectile Dysfunction Revenue by Type (2017-2028) 44
6.2 North America Erectile Dysfunction Market Size by Application 45
6.2.1 North America Erectile Dysfunction Sales by Application (2017-2028) 45
6.2.2 North America Erectile Dysfunction Revenue by Application (2017-2028) 46
6.3 North America Erectile Dysfunction Sales by Country 47
6.3.1 North America Erectile Dysfunction Sales by Country (2017-2028) 47
6.3.2 North America Erectile Dysfunction Revenue by Country (2017-2028) 48
6.3.3 United States 49
6.3.4 Canada 50
7 EUROPE 51
7.1 Europe Erectile Dysfunction Market Size by Type 51
7.1.1 Europe Erectile Dysfunction Sales by Type (2017-2028) 51
7.1.2 Europe Erectile Dysfunction Revenue by Type (2017-2028) 52
7.2 Europe Erectile Dysfunction Market Size by Application 53
7.2.1 Europe Erectile Dysfunction Sales by Application (2017-2028) 53
7.2.2 Europe Erectile Dysfunction Revenue by Application (2017-2028) 54
7.3 Europe Erectile Dysfunction Market Size by Country 55
7.3.1 Europe Erectile Dysfunction Sales by Country (2017-2028) 55
7.3.2 Europe Erectile Dysfunction Revenue by Country (2017-2028) 56
7.3.3 Germany 58
7.3.4 France 58
7.3.5 U.K. 59
7.3.6 Italy 59
7.3.7 Russia 60
8 ASIA PACIFIC 61
8.1 Asia Pacific Erectile Dysfunction Market Size by Type 61
8.1.1 Asia Pacific Erectile Dysfunction Sales by Type (2017-2028) 61
8.1.2 Asia Pacific Erectile Dysfunction Revenue by Type (2017-2028) 62
8.2 Asia Pacific Erectile Dysfunction Market Size by Application 63
8.2.1 Asia Pacific Erectile Dysfunction Sales by Application (2017-2028) 63
8.2.2 Asia Pacific Erectile Dysfunction Revenue by Application (2017-2028) 64
8.3 Asia Pacific Erectile Dysfunction Market Size by Region 65
8.3.1 Asia Pacific Erectile Dysfunction Sales by Region (2017-2028) 65
8.3.2 Asia Pacific Erectile Dysfunction Revenue by Region (2017-2028) 67
8.3.3 China 69
8.3.4 Japan 69
8.3.5 South Korea 70
8.3.6 India 70
8.3.7 Australia 71
8.3.8 China Taiwan 71
8.3.9 Indonesia 72
8.3.10 Thailand 72
8.3.11 Malaysia 73
9 LATIN AMERICA 74
9.1 Latin America Erectile Dysfunction Market Size by Type 74
9.1.1 Latin America Erectile Dysfunction Sales by Type (2017-2028) 74
9.1.2 Latin America Erectile Dysfunction Revenue by Type (2017-2028) 75
9.2 Latin America Erectile Dysfunction Market Size by Application 76
9.2.1 Latin America Erectile Dysfunction Sales by Application (2017-2028) 76
9.2.2 Latin America Erectile Dysfunction Revenue by Application (2017-2028) 77
9.3 Latin America Erectile Dysfunction Market Size by Country 78
9.3.1 Latin America Erectile Dysfunction Sales by Country (2017-2028) 78
9.3.2 Latin America Erectile Dysfunction Revenue by Country (2017-2028) 79
9.3.3 Brazil 80
9.3.4 Argentina 81
10 MIDDLE EAST AND AFRICA 82
10.1 Middle East and Africa Erectile Dysfunction Market Size by Type 82
10.1.1 Middle East and Africa Erectile Dysfunction Sales by Type (2017-2028) 82
10.1.2 Middle East and Africa Erectile Dysfunction Revenue by Type (2017-2028) 83
10.2 Middle East and Africa Erectile Dysfunction Market Size by Application 84
10.2.1 Middle East and Africa Erectile Dysfunction Sales by Application (2017-2028) 84
10.2.2 Middle East and Africa Erectile Dysfunction Revenue by Application (2017-2028) 85
10.3 Middle East and Africa Erectile Dysfunction Market Size by Country 86
10.3.1 Middle East and Africa Erectile Dysfunction Sales by Country (2017-2028) 86
10.3.2 Middle East and Africa Erectile Dysfunction Revenue by Country (2017-2028) 87
10.3.3 Turkey 89
10.3.4 Saudi Arabia 89
10.3.5 UAE 90
11 CORPORATE PROFILE 91
11.1 Eli Lilly 91
11.1.1 Eli Lilly Corporation Information 91
11.1.2 Eli Lilly Overview 91
11.1.3 Eli Lilly Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 92
11.1.4 Eli Lilly Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 92
11.1.5 Eli Lilly Recent Developments 93
11.2 Pfizer 93
11.2.1 Pfizer Corporation Information 93
11.2.2 Pfizer Overview 93
11.2.3 Pfizer Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 94
11.2.4 Pfizer Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 94
11.2.5 Pfizer Recent Developments 95
11.3 Bayer 95
11.3.1 Bayer Corporation Information 95
11.3.2 Bayer Overview 96
11.3.3 Bayer Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 97
11.3.4 Bayer Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 97
11.3.5 Bayer Recent Developments 98
11.4 BaiYunShan General Factory 98
11.4.1 BaiYunShan General Factory Corporation Information 98
11.4.2 BaiYunShan General Factory Overview 99
11.4.3 BaiYunShan General Factory Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 100
11.4.4 BaiYunShan General Factory Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 100
11.4.5 BaiYunShan General Factory Recent Developments 101
11.5 S.K. Chemicals 101
11.5.1 S.K. Chemicals Corporation Information 101
11.5.2 S.K. Chemicals Overview 101
11.5.3 S.K. Chemicals Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 102
11.5.4 S.K. Chemicals Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 102
11.5.5 S.K. Chemicals Recent Developments 103
11.6 Teva Pharma 103
11.6.1 Teva Pharma Corporation Information 103
11.6.2 Teva Pharma Overview 104
11.6.3 Teva Pharma Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 104
11.6.4 Teva Pharma Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 105
11.6.5 Teva Pharma Recent Developments 105
11.7 Dong-A ST 106
11.7.1 Dong-A ST Corporation Information 106
11.7.2 Dong-A ST Overview 106
11.7.3 Dong-A ST Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 107
11.7.4 Dong-A ST Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 107
11.7.5 Dong-A ST Recent Developments 108
11.8 Petros Pharmaceuticals 108
11.8.1 Petros Pharmaceuticals Corporation Information 108
11.8.2 Petros Pharmaceuticals Overview 109
11.8.3 Petros Pharmaceuticals Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 109
11.8.4 Petros Pharmaceuticals Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 109
11.8.5 Petros Pharmaceuticals Recent Developments 110
11.9 Seoul Pharma 110
11.9.1 Seoul Pharma Corporation Information 110
11.9.2 Seoul Pharma Overview 111
11.9.3 Seoul Pharma Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 111
11.9.4 Seoul Pharma Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 111
11.9.5 Seoul Pharma Recent Developments 112
11.10 Yabang Pharmacy 113
11.10.1 Yabang Pharmacy Corporation Information 113
11.10.2 Yabang Pharmacy Overview 113
11.10.3 Yabang Pharmacy Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 114
11.10.4 Yabang Pharmacy Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 114
11.10.5 Yabang Pharmacy Recent Developments 115
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 116
12.1 Erectile Dysfunction Industry Chain Analysis 116
12.2 Erectile Dysfunction Key Raw Materials 116
12.2.1 Key Raw Materials 116
12.2.2 Raw Materials Key Suppliers 116
12.3 Erectile Dysfunction Production Mode & Process 117
12.4 Erectile Dysfunction Sales and Marketing 118
12.4.1 Erectile Dysfunction Sales Channels 118
12.4.2 Erectile Dysfunction Distributors 118
12.5 Erectile Dysfunction Customers 120
13 ERECTILE DYSFUNCTION MARKET DYNAMICS 121
13.1.1 Erectile Dysfunction Industry Trends 121
13.1.2 Erectile Dysfunction Market Drivers 121
13.1.3 Erectile Dysfunction Market Challenges 122
13.1.4 Erectile Dysfunction Market Restraints 122
14 KEY FINDINGS IN THE GLOBAL ERECTILE DYSFUNCTION STUDY 123
15 APPENDIX 124
15.1 Research Methodology 124
15.1.1 Methodology/Research Approach 124
15.1.2 Data Source 127
15.2 Author Details 129
15.3 Disclaimer 130